Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Epoetin alfa RB · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Epoetin alfa RB | ACTIVE_COMPARATOR | - |
| Epoetin alfa DT | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| Epoetin alfa RB | DRUG | Receive drug at same frequency and dose as at the time of randomization Change dose by+/- 25% in order to maintain Hb between 10.0 - 13.0 g/dL and within -1.0 to +1.5 g/dL of the subject's baseline Hb. |
| Epoetin alfa DT | DRUG | Receive drug at same frequency and dose as at the time of randomization Change dose by+/- 25% in order to maintain Hb between 10.0 - 13.0 g/dL and within -1.0 to +1.5 g/dL of the subject's baseline Hb. |
Inclusion Criteria: - Diagnosis of CKD and receiving hemodialysis for greater than or equal to 3 months before randomization - Mean HB level between 10 and 13 g/dL (inclusive) (mean of 2 values drawn at least 3 days apart during the screening period) - Currently receiving a stable dose of Epoetin al...